(Keytruda is US registered trademarks of Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., INC., USA.)

What is Keytruda:

Keytruda is a prescription medicine that contains the active substance pembrolizumabwhich is available as lyophilized powder that is made up into solution for infusion (drip into vein). This also comes in ready solution but for different strength.

Which company market and owner of Keytruda brand:

Keytruda is product of Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., INC., USA.Keytruda is US registered trademarks of Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., INC., USA.

In how many countries Keytruda is approved for marketing:

Keytrudais approved in many countries, including Japan, the United States and countries in the European Union.Keytruda is not approved for marketing in India

What is Keytruda used for:

  • In patients with un-resectable or metastatic melanoma which is type of skin cancer
  • In a patient who is suffering from metastatic Non-small cell lung Cancer (NSCLC) whose tumors have high PD-L1 expression with no EGFR or ALK tumor aberrations and has not be given prior chemotherapy treatment for the same disease. NSCLC is a type of lung cancer.
  • In a metastatic NSCLC patients whose tumor having high PD-L1 expression and have received chemotherapy that contains platinum to treat advanced NSCLC, and it did not work or it is no longer working.
  • In patients who have Head and Neck Squamous Cell cancer (HNSCC) when it is spread or relapsed (come back) where patients has received platinum based chemotherapy previously.

How can I getKeytruda in India?

Keytruda is a prescription only drug, but not yet approved for marketing in India. However, as per the Drugs and Cosmetic Act 1940 and Rules 1945, provisions are in place for the personal import of unapproved drugs in India by a patient

Ikris Pharma Network (IPN) is a consulting pharmaceutical company which assists Patientsin preparing documentation for Name-Patient Medicine Import for their personal use. Ikris Pharma Network facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact IPN at + 91 120 2400370 or write to at – Our manager will get in touch with you to guide you further and will assist you in doing all the paper work for securing necessary permissions from Govt.of India before Keytrudais imported directly to you.

Ikris does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees

Can I getKeytruda even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior tomarketing approval for personal use for patients who have exhausted all other treatment options available in their country
IKRIS Pharma Network (IPN) can assist patients in accessingKeytruda even if it is unapproved against valid prescriptions in conformity with all local laws and regulations.

How is Keytruda used?

Keytruda should be administered under the guidance of specialist doctorhaving experience in managing cancer treatments

The recommended dose is 2mg/kg body weight if it is used to treat indicated cases of melanoma. It is given by a 30-minute infusion into a vein every three weeks. Patients should always be monitored during and after the infusion for certain side effects and full blood counts should be checked before every dose of Keytruda.

Dosage are 200mg every 3 weeks if Keytruda is given to treat indicated cases of NSCLC. Same dose is recommended i.e. 200mg every 3 weeks if Keytruda is given to treat specific case of HNSCC.

If the patient develops certain seriousside effects then doctor may interrupt or stop treatment, or reduce the dose. See the summary of product characteristics on company official website for more information


Contact Details

IKRIS Pharma Network Pvt. Ltd.
905 , I - Thum Business Park,
Plot No. A-40, Unit No. 5, Tower A,
Sector-62, Noida – 201301 (India)

Phone No.- +91-120–2400370.
M: + 91 8130290915

WhatsApp: +91 8130290915
QQID:- 1927411523
Skype ID: praveen.sikri

Query Form

Are there any side-effects/ adverse reactions/precautions associated with treatment with KEYTRUDA?

It is recommended to seek your doctor’s medical advice about side effects

How do I contact Ikris Pharma Network?

You can use different channel to contact Ikris Pharma Network
Tele & Mobile: You can reach us on +91 81302 90915 or +91 120 2400370 on any working days.
Email: We can also address your enquiries if sent directly to We will respond within 24 hours after receiving your mail. Please mention detailed enquiry, your contact number withwith ISD code while sending your mail
Website: We have very active website www.ikrispharmanetwork.comwherein you can fill enquiry form displayed on the website. We will respond within 1 working days after receiving your query form.
Office: We will be happy to address your query directly if you can plan your visit to our office during working hours. Our office address is……. (please include google map here)

What is Named Patient Program?

New medicines which have been approved recently in USA or Europe but not yet approved in India or Rest of the world countries cannot be permitted to import or market commercially. However, they may be required for the treatment of some patients to save their lives who have exhausted all other available treatment options in their home country. Named – Patient Program is facilitate import of such medicines for personal use. There is a provision under the Indian Drugs and Cosmetics Rules, 1945, which permits needy patient to import these medicine for personal use in smaller quantities. Similar regulatory provision also exist in other countries as well.
We help such patient in preparing legal documents for import and connecting them with genuine suppliers to secure genuine products.

What information do youneed tohelp patient in assisting documentation for Keytruda import for personal use?

We will require the following documents to help in documentation for Named-Patient import

  • a. Doctor’s Prescription – We would require prescription from Registered Medical Practitioner stating Product name, dosage, duration of treatment and diagnosis
  • b. Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
  • c. Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.